Efficacy and Safety of Original Versus Generic Erlotinib in Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor Gene Mutations in Thailand: A Retrospective Cohort Study. Pharm Pract (Granada) [Internet]. 2025 Oct. 8 [cited 2026 Apr. 17];23(3):1-7. Available from: https://www.pharmacypractice.org/index.php/pp/article/view/3257